Third Harmonic Bio, Inc. financial data

Symbol
THRD on Nasdaq
Industry
Pharmaceutical Preparations
Location
1700 Montgomery Street, Suite 210, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 5.6 K %
Debt-to-equity 3.02 %
Return On Equity -10.9 % +39.4%
Return On Assets -10.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.7 M shares +0.97%
Common Stock, Shares, Outstanding 40.3 M shares +1.95%
Entity Public Float 86.1 M USD
Common Stock, Value, Issued 4 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 40.2 M shares +1.96%
Weighted Average Number of Shares Outstanding, Diluted 40.2 M shares +1.96%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 23.5 M USD -5.93%
General and Administrative Expense 19.8 M USD +16.6%
Operating Income (Loss) -43.3 M USD -3.21%
Nonoperating Income (Expense) 13.7 M USD +151%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30.8 M USD +12.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -29.6 M USD +18.8%
Earnings Per Share, Basic 0.75 USD/shares -12.8%
Earnings Per Share, Diluted 0.75 USD/shares -12.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 263 M USD -6.87%
Assets, Current 266 M USD -7.05%
Deferred Income Tax Assets, Net 25.5 M USD +39.8%
Property, Plant and Equipment, Net 157 K USD +162%
Operating Lease, Right-of-Use Asset 3.59 M USD -15.7%
Other Assets, Noncurrent 725 K USD -17.8%
Assets 271 M USD -7.16%
Accounts Payable, Current 945 K USD -64.6%
Liabilities, Current 4.02 M USD -18.8%
Operating Lease, Liability, Noncurrent 3 M USD -20.5%
Liabilities 7.02 M USD -19.5%
Retained Earnings (Accumulated Deficit) -122 M USD -32%
Stockholders' Equity Attributable to Parent 264 M USD -6.78%
Liabilities and Equity 271 M USD -7.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.29 M USD +5.72%
Net Cash Provided by (Used in) Financing Activities 49 K USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500 M shares 0%
Common Stock, Shares, Issued 40.3 M shares +1.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.24 M USD +6.46%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 270 M USD -6.84%
Deferred Tax Assets, Valuation Allowance 25.5 M USD +39.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 26.7 M USD +34.9%
Operating Lease, Liability 3.78 M USD -15%
Depreciation 12 K USD +300%
Payments to Acquire Property, Plant, and Equipment 0 USD
Lessee, Operating Lease, Liability, to be Paid 4.6 M USD -19.2%
Property, Plant and Equipment, Gross 204 K USD +224%
Operating Lease, Liability, Current 773 K USD +15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.18 M USD +2.71%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.15 M USD +2.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 828 K USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.21 M USD +2.64%
Deferred Tax Assets, Operating Loss Carryforwards 12 M USD +16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.21 M USD +2.64%
Operating Lease, Payments 1.13 M USD
Additional Paid in Capital 386 M USD +2.78%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 9.12 M USD +30.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%